HSP27 is also involved in the process of prostate cancer metastasis through the promotion of IL-6-mediated epithelial-to-mesenchymal transition (EMT), because reduced HSP27 expression decreases cell migration and invasion [134]. This evidence concerns the gene HSPB1 and prostate carcinoma.